Bio Imaging Technologies Market Share & Trends Analysis Report, By Technology (Confocal Microscopy, Super-Resolution Microscopy, Electron Microscopy, Multiphoton Microscopy), By Application (Cell Biology, Neuroscience, Developmental Biology, Cancer Research), By Sample Type, By End User, By Region, and Segment Forecasts, 2024-2031
The Bio Imaging Technologies Market Size is valued at USD 22.5 Bn in 2023 and is predicted to reach USD 37.7 Bn by the year 2031 at an 6.8% CAGR during the forecast period for 2024-2031. Bio-imaging technologies are used to observe biological structures, functions, and processes at the cellular, tissue, or molecular level. These technologies enable scientists and medical professionals to obtain precise images of biological samples or living or...
Report ID: 2828 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 165
Lateral Flow Assay Market Size, Share & Trends Analysis Report By Type (Kits & Reagents, Lateral Flow Readers), By Application, By Technique, By Sample Type, By End Users, By Region, And By Segment Forecasts, 2023-2031.
Lateral Flow Assay Market Size is valued at USD 20.65 Bn in 2023 and is predicted to reach USD 24.45 Bn by the year 2031 at a 2.21% CAGR during the forecast period for 2024-2031. Immunochromatographic tests, known as lateral flow assays, can determine if a target analyte, such as a pathogen or a biomarker, is present or absent in people or animals. Due to increased usage in medical diagnostics, a rise in the occurrence of infectious disea...
Report ID: 2729 |
Delivery: Immediate |
Published: September 2024 |
No. of Pages: 180
Recombinant Cell Culture Supplements Market Size and Revenue Impact Study 2025 to 2034
Global Recombinant Cell Culture Supplements Market Size is valued at USD 388.35 Mn in 2023 and is predicted to reach USD 1008.85 Mn by the year 2031 at a 12.75% CAGR during the forecast period for 2024 to 2031. Recombinant Cell Culture Supplements Market Size, Share & Trends Analysis Report by Product (recombinant albumin (rAlbumin), recombinant insulin (rInsulin), recombinant epidermal growth factor (rEGF), recombinant inter...
Report ID: 1847 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Recombinant Chemicals Market Size, Share & Trends Analysis Report By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application, By Region, And By Segment Forecasts, 2024-2031
The Recombinant Chemicals Market Size is valued at USD 2.87 billion in 2023 and is predicted to reach USD 4.67 billion by the year 2031 at a 6.4% CAGR during the forecast period for 2024-2031. Recombinant chemicals are products or substances that are generated using recombinant DNA technology, which involves combining DNA from multiple sources to create novel genetic combinations. Biotechnology frequently use this procedure to produce a wide r...
Report ID: 2663 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 170
Pharmaceutical CRDMO Services Market Size, Share & Trends Analysis Report By Type (Small molecular CRDMO service, Middle molecular CRDMO service, Large molecular CRDMO service, By Application (Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Diseases, Hematology, Vaccine), By Region, And By Segment Forecasts, 2024-2031.
Pharmaceutical CRDMO Services Market Size is valued at USD 114.8 billion in 2023 and is predicted to reach USD 266.7 billion by the year 2031 at an 11.3% CAGR during the forecast period for 2024-2031. Pharmaceutical Contract Research, Development, and Manufacturing Organization (CRDMO) services provide a comprehensive and unified solution for drug development, encompassing research, development, and manufacturing. These services encompass the ...
Report ID: 2651 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 180
Next Generation Bioprinting Market Forecast with Size and Share Analysis 2026 to 2035
Global Next Generation Bioprinting Market Size is valued projected to record a 29.82 % CAGR during the forecast period for 2024 to 2031. Next Generation Bioprinting Market Size, Share & Trends Analysis Report By Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology, Others), By Application (Biomedical Applications, Other Applications), By End-user, Region And Segment Forecasts, 2026 to 2035 K...
Report ID: 1941 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
In-vitro Transcription Templates Market Size, Share & Trends Analysis Report By Disease Type (Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others), Infectious Disease (Influenza, COVID-19, AIDS, Others), Lifestyle Disease, Genetic Disease, Others), By Treatment (Vaccine, Therapeutic), By Research Stage (Exploratory, Clinical), By End-User (Pharmaceutical & Biotechnology Companies, CROs & CMOs, Academics & Research, Others), By Region, And By Segment Forecasts, 2024-2031
In-vitro Transcription Templates Market Size is valued at USD 277.5 Mn in 2023 and is predicted to reach USD 1,134.1 Mn by the year 2031 at a 19.5% CAGR during the forecast period for 2024-2031. In-vitro transcription templates are essential for a range of research and diagnostic purposes. These include creating mRNA for gene expression analysis, producing probes for RNA hybridization assays, and generating templates for in-vitro translation. ...
Report ID: 2397 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Baculovirus Expression System Market Size, Share & Trends Analysis Report By Product Type (Baculovirus, Expression Vector, Reagents, Others), By Application (Therapeutics, Vaccines, Protein Purification, Others), By End User (Biopharmaceutical Companies, Research Institutes, Others), By Region, And By Segment Forecasts, 2024-2031
Baculovirus Expression System Market Size is valued at USD 374.79 Mn in 2023 and is predicted to reach USD 660.97 Mn by the year 2031 at a 7.43% CAGR during the forecast period for 2024-2031. The baculovirus vector system induces recombinant protein expression in insect cell cultures. It is one of the most adaptable and robust methods for the eukaryotic expression of recombinant proteins. This technique allows for the efficient manu...
Report ID: 2227 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 180
Pharmaceuticals